nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropinirole—DRD5—attention deficit hyperactivity disorder	0.173	0.212	CbGaD
Ropinirole—ADRA2C—attention deficit hyperactivity disorder	0.163	0.2	CbGaD
Ropinirole—DRD4—attention deficit hyperactivity disorder	0.0883	0.108	CbGaD
Ropinirole—HTR1B—attention deficit hyperactivity disorder	0.0784	0.0961	CbGaD
Ropinirole—DRD3—attention deficit hyperactivity disorder	0.0761	0.0933	CbGaD
Ropinirole—DRD1—attention deficit hyperactivity disorder	0.0747	0.0916	CbGaD
Ropinirole—ADRA2A—attention deficit hyperactivity disorder	0.0694	0.0851	CbGaD
Ropinirole—DRD2—attention deficit hyperactivity disorder	0.0527	0.0646	CbGaD
Ropinirole—HTR2A—attention deficit hyperactivity disorder	0.0407	0.0499	CbGaD
Ropinirole—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00333	0.0855	CbGeAlD
Ropinirole—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00177	0.0454	CbGeAlD
Ropinirole—DRD5—forebrain—attention deficit hyperactivity disorder	0.00139	0.0355	CbGeAlD
Ropinirole—DRD1—forebrain—attention deficit hyperactivity disorder	0.00106	0.0272	CbGeAlD
Ropinirole—DRD4—brain—attention deficit hyperactivity disorder	0.000873	0.0224	CbGeAlD
Ropinirole—HTR1B—forebrain—attention deficit hyperactivity disorder	0.000858	0.022	CbGeAlD
Ropinirole—HTR1D—forebrain—attention deficit hyperactivity disorder	0.000831	0.0213	CbGeAlD
Ropinirole—HTR2C—forebrain—attention deficit hyperactivity disorder	0.000823	0.0211	CbGeAlD
Ropinirole—DRD3—nervous system—attention deficit hyperactivity disorder	0.000803	0.0206	CbGeAlD
Ropinirole—DRD3—central nervous system—attention deficit hyperactivity disorder	0.000773	0.0198	CbGeAlD
Ropinirole—HTR2B—forebrain—attention deficit hyperactivity disorder	0.000773	0.0198	CbGeAlD
Ropinirole—DRD5—nervous system—attention deficit hyperactivity disorder	0.000753	0.0193	CbGeAlD
Ropinirole—HTR1B—cardiovascular system—attention deficit hyperactivity disorder	0.000726	0.0186	CbGeAlD
Ropinirole—DRD5—central nervous system—attention deficit hyperactivity disorder	0.000725	0.0186	CbGeAlD
Ropinirole—HTR1D—cardiovascular system—attention deficit hyperactivity disorder	0.000703	0.018	CbGeAlD
Ropinirole—DRD1—midbrain—attention deficit hyperactivity disorder	0.0007	0.0179	CbGeAlD
Ropinirole—HTR1A—forebrain—attention deficit hyperactivity disorder	0.000693	0.0178	CbGeAlD
Ropinirole—HTR2B—cardiovascular system—attention deficit hyperactivity disorder	0.000654	0.0168	CbGeAlD
Ropinirole—DRD2—forebrain—attention deficit hyperactivity disorder	0.000626	0.016	CbGeAlD
Ropinirole—DRD3—brain—attention deficit hyperactivity disorder	0.000614	0.0157	CbGeAlD
Ropinirole—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.000586	0.015	CbGeAlD
Ropinirole—DRD5—brain—attention deficit hyperactivity disorder	0.000575	0.0147	CbGeAlD
Ropinirole—DRD1—nervous system—attention deficit hyperactivity disorder	0.000575	0.0147	CbGeAlD
Ropinirole—HTR1B—midbrain—attention deficit hyperactivity disorder	0.000567	0.0145	CbGeAlD
Ropinirole—DRD1—central nervous system—attention deficit hyperactivity disorder	0.000554	0.0142	CbGeAlD
Ropinirole—HTR1D—midbrain—attention deficit hyperactivity disorder	0.000549	0.0141	CbGeAlD
Ropinirole—HTR2C—midbrain—attention deficit hyperactivity disorder	0.000543	0.0139	CbGeAlD
Ropinirole—ADRA2A—forebrain—attention deficit hyperactivity disorder	0.000486	0.0124	CbGeAlD
Ropinirole—HTR1B—nervous system—attention deficit hyperactivity disorder	0.000466	0.0119	CbGeAlD
Ropinirole—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000457	0.0117	CbGeAlD
Ropinirole—HTR1D—nervous system—attention deficit hyperactivity disorder	0.000451	0.0116	CbGeAlD
Ropinirole—HTR1B—central nervous system—attention deficit hyperactivity disorder	0.000449	0.0115	CbGeAlD
Ropinirole—HTR2C—nervous system—attention deficit hyperactivity disorder	0.000447	0.0115	CbGeAlD
Ropinirole—DRD1—brain—attention deficit hyperactivity disorder	0.00044	0.0113	CbGeAlD
Ropinirole—HTR1D—central nervous system—attention deficit hyperactivity disorder	0.000434	0.0111	CbGeAlD
Ropinirole—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.00043	0.011	CbGeAlD
Ropinirole—HTR2B—nervous system—attention deficit hyperactivity disorder	0.00042	0.0108	CbGeAlD
Ropinirole—DRD2—midbrain—attention deficit hyperactivity disorder	0.000413	0.0106	CbGeAlD
Ropinirole—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000413	0.0106	CbGeAlD
Ropinirole—HTR2B—central nervous system—attention deficit hyperactivity disorder	0.000404	0.0104	CbGeAlD
Ropinirole—ADRA2C—midbrain—attention deficit hyperactivity disorder	0.000402	0.0103	CbGeAlD
Ropinirole—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000376	0.00964	CbGeAlD
Ropinirole—HTR1A—nervous system—attention deficit hyperactivity disorder	0.000376	0.00964	CbGeAlD
Ropinirole—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000362	0.00928	CbGeAlD
Ropinirole—HTR1B—brain—attention deficit hyperactivity disorder	0.000356	0.00913	CbGeAlD
Ropinirole—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.000354	0.00907	CbGeAlD
Ropinirole—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000349	0.00895	CbGeAlD
Ropinirole—HTR1D—brain—attention deficit hyperactivity disorder	0.000345	0.00884	CbGeAlD
Ropinirole—HTR2C—brain—attention deficit hyperactivity disorder	0.000341	0.00875	CbGeAlD
Ropinirole—DRD2—nervous system—attention deficit hyperactivity disorder	0.00034	0.00871	CbGeAlD
Ropinirole—ADRA2C—nervous system—attention deficit hyperactivity disorder	0.00033	0.00847	CbGeAlD
Ropinirole—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000327	0.00839	CbGeAlD
Ropinirole—HTR2B—brain—attention deficit hyperactivity disorder	0.000321	0.00822	CbGeAlD
Ropinirole—ADRA2A—midbrain—attention deficit hyperactivity disorder	0.000321	0.00822	CbGeAlD
Ropinirole—DRD2—cerebellum—attention deficit hyperactivity disorder	0.00032	0.0082	CbGeAlD
Ropinirole—ADRA2C—central nervous system—attention deficit hyperactivity disorder	0.000318	0.00815	CbGeAlD
Ropinirole—ADRA2C—cerebellum—attention deficit hyperactivity disorder	0.000311	0.00797	CbGeAlD
Ropinirole—HTR1A—brain—attention deficit hyperactivity disorder	0.000287	0.00737	CbGeAlD
Ropinirole—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000273	0.00699	CbGeAlD
Ropinirole—ADRA2A—nervous system—attention deficit hyperactivity disorder	0.000264	0.00676	CbGeAlD
Ropinirole—DRD2—brain—attention deficit hyperactivity disorder	0.00026	0.00666	CbGeAlD
Ropinirole—ADRA2A—central nervous system—attention deficit hyperactivity disorder	0.000254	0.00651	CbGeAlD
Ropinirole—ADRA2C—brain—attention deficit hyperactivity disorder	0.000252	0.00647	CbGeAlD
Ropinirole—ADRA2A—cerebellum—attention deficit hyperactivity disorder	0.000248	0.00636	CbGeAlD
Ropinirole—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000224	0.00575	CbGeAlD
Ropinirole—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000216	0.00553	CbGeAlD
Ropinirole—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000211	0.00541	CbGeAlD
Ropinirole—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000207	0.00532	CbGeAlD
Ropinirole—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000204	0.00523	CbGeAlD
Ropinirole—ADRA2A—brain—attention deficit hyperactivity disorder	0.000201	0.00516	CbGeAlD
Ropinirole—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.0002	0.00512	CbGeAlD
Ropinirole—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000197	0.00504	CbGeAlD
Ropinirole—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000192	0.00493	CbGeAlD
Ropinirole—HTR2A—brain—attention deficit hyperactivity disorder	0.000171	0.00439	CbGeAlD
Ropinirole—CYP2D6—brain—attention deficit hyperactivity disorder	0.000156	0.004	CbGeAlD
Ropinirole—DRD5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.34e-05	9.2e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	1.33e-05	9.15e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.32e-05	9.11e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.32e-05	9.1e-05	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.32e-05	9.09e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.32e-05	9.05e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.31e-05	9.04e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	1.31e-05	9.04e-05	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	1.31e-05	9.04e-05	CbGpPWpGaD
Ropinirole—HTR1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.31e-05	9.02e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.31e-05	9.01e-05	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.3e-05	8.97e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.3e-05	8.92e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.29e-05	8.9e-05	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	1.29e-05	8.89e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.29e-05	8.85e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.28e-05	8.83e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.28e-05	8.79e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.28e-05	8.79e-05	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	1.28e-05	8.78e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.28e-05	8.78e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.27e-05	8.76e-05	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.27e-05	8.75e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.27e-05	8.74e-05	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.27e-05	8.72e-05	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	1.26e-05	8.7e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.26e-05	8.69e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.26e-05	8.64e-05	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.25e-05	8.61e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.25e-05	8.61e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.25e-05	8.61e-05	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	1.25e-05	8.6e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.24e-05	8.5e-05	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.23e-05	8.5e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.23e-05	8.48e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.23e-05	8.47e-05	CbGpPWpGaD
Ropinirole—HTR1D—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.23e-05	8.46e-05	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	1.23e-05	8.46e-05	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.23e-05	8.46e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.23e-05	8.44e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.22e-05	8.38e-05	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.21e-05	8.36e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.21e-05	8.31e-05	CbGpPWpGaD
Ropinirole—HTR1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.2e-05	8.29e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.19e-05	8.21e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.19e-05	8.19e-05	CbGpPWpGaD
Ropinirole—DRD4—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.19e-05	8.16e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.18e-05	8.14e-05	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	1.18e-05	8.09e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.17e-05	8.07e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.16e-05	7.99e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—TPH2—attention deficit hyperactivity disorder	1.16e-05	7.99e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.16e-05	7.96e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.16e-05	7.95e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.15e-05	7.92e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.15e-05	7.9e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.15e-05	7.9e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.14e-05	7.86e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—DPYD—attention deficit hyperactivity disorder	1.14e-05	7.86e-05	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.14e-05	7.83e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.14e-05	7.82e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.14e-05	7.81e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.13e-05	7.8e-05	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.13e-05	7.79e-05	CbGpPWpGaD
Ropinirole—HTR2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.13e-05	7.79e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.12e-05	7.72e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.12e-05	7.7e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.12e-05	7.69e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.12e-05	7.69e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.11e-05	7.67e-05	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.11e-05	7.61e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.1e-05	7.59e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.1e-05	7.56e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.09e-05	7.53e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.08e-05	7.41e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.08e-05	7.4e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.07e-05	7.35e-05	CbGpPWpGaD
Ropinirole—DRD1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.07e-05	7.34e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.06e-05	7.32e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.06e-05	7.31e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.05e-05	7.25e-05	CbGpPWpGaD
Ropinirole—DRD3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.05e-05	7.24e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.04e-05	7.17e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.04e-05	7.13e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.03e-05	7.11e-05	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.03e-05	7.09e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.03e-05	7.07e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.03e-05	7.07e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.02e-05	7.05e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.02e-05	7.04e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.02e-05	7.02e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.01e-05	6.96e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1e-05	6.91e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1e-05	6.91e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1e-05	6.91e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1e-05	6.9e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.9e-06	6.81e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.9e-06	6.81e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.89e-06	6.81e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	9.87e-06	6.79e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.87e-06	6.79e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	9.82e-06	6.76e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.69e-06	6.67e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.58e-06	6.59e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.56e-06	6.58e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	9.55e-06	6.58e-05	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	9.51e-06	6.54e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—TPH2—attention deficit hyperactivity disorder	9.43e-06	6.49e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.43e-06	6.49e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	9.42e-06	6.48e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.42e-06	6.48e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	9.35e-06	6.43e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.3e-06	6.4e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.29e-06	6.39e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—DPYD—attention deficit hyperactivity disorder	9.28e-06	6.39e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	9.23e-06	6.35e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.21e-06	6.34e-05	CbGpPWpGaD
Ropinirole—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	9.18e-06	6.31e-05	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	9.13e-06	6.28e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	9.08e-06	6.25e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.04e-06	6.22e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	8.94e-06	6.15e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	8.91e-06	6.13e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.88e-06	6.11e-05	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	8.88e-06	6.11e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.84e-06	6.08e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.77e-06	6.04e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.76e-06	6.03e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	8.67e-06	5.97e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.67e-06	5.96e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.66e-06	5.96e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.63e-06	5.94e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	8.63e-06	5.94e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.63e-06	5.94e-05	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.62e-06	5.93e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	8.59e-06	5.91e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	8.53e-06	5.87e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	8.35e-06	5.75e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.33e-06	5.73e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.31e-06	5.72e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.29e-06	5.7e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.17e-06	5.62e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.06e-06	5.55e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.06e-06	5.55e-05	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	8.06e-06	5.54e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.05e-06	5.54e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.02e-06	5.52e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.98e-06	5.49e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Hemostasis—EP300—attention deficit hyperactivity disorder	7.97e-06	5.48e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	7.91e-06	5.45e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.82e-06	5.38e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.77e-06	5.35e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.76e-06	5.34e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	7.76e-06	5.34e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.73e-06	5.32e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	7.64e-06	5.26e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	7.6e-06	5.23e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	7.58e-06	5.21e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	7.55e-06	5.19e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.54e-06	5.19e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.54e-06	5.19e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.52e-06	5.17e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.51e-06	5.16e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	7.46e-06	5.13e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Hemostasis—EP300—attention deficit hyperactivity disorder	7.44e-06	5.12e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	7.39e-06	5.09e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	7.32e-06	5.03e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.3e-06	5.02e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.28e-06	5.01e-05	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	7.21e-06	4.96e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.05e-06	4.85e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—COMT—attention deficit hyperactivity disorder	7.04e-06	4.84e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.03e-06	4.84e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.99e-06	4.81e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—MAOA—attention deficit hyperactivity disorder	6.99e-06	4.81e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.93e-06	4.77e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.82e-06	4.7e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.8e-06	4.68e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.78e-06	4.67e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.71e-06	4.62e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.71e-06	4.62e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.62e-06	4.56e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.6e-06	4.54e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.6e-06	4.54e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	6.55e-06	4.51e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.52e-06	4.48e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.46e-06	4.45e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.36e-06	4.38e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.31e-06	4.34e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	6.15e-06	4.23e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	6.15e-06	4.23e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.11e-06	4.2e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.07e-06	4.18e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.07e-06	4.18e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	6.05e-06	4.16e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Hemostasis—EP300—attention deficit hyperactivity disorder	6.05e-06	4.16e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.93e-06	4.08e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	5.82e-06	4.01e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.72e-06	3.94e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—COMT—attention deficit hyperactivity disorder	5.72e-06	3.93e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—MAOA—attention deficit hyperactivity disorder	5.68e-06	3.91e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.65e-06	3.89e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.62e-06	3.87e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.52e-06	3.8e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	5.21e-06	3.58e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.21e-06	3.58e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	5.12e-06	3.53e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.1e-06	3.51e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.92e-06	3.39e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.91e-06	3.38e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.9e-06	3.37e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.76e-06	3.28e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.76e-06	3.28e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.68e-06	3.22e-05	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.56e-06	3.14e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.32e-06	2.97e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.16e-06	2.87e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	4.02e-06	2.77e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.02e-06	2.77e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.96e-06	2.73e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	3.95e-06	2.72e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.87e-06	2.66e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	3.72e-06	2.56e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	3.7e-06	2.54e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.68e-06	2.53e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.5e-06	2.41e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.42e-06	2.36e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.37e-06	2.32e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.22e-06	2.21e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.21e-06	2.21e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	3.16e-06	2.17e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	3.13e-06	2.16e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.06e-06	2.1e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	3.04e-06	2.09e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.03e-06	2.09e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—EP300—attention deficit hyperactivity disorder	3.02e-06	2.08e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.99e-06	2.06e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.7e-06	1.86e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.61e-06	1.79e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.59e-06	1.79e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.52e-06	1.74e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—EP300—attention deficit hyperactivity disorder	2.45e-06	1.69e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	2.44e-06	1.68e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	2.42e-06	1.66e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.29e-06	1.58e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.25e-06	1.55e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.05e-06	1.41e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	1.6e-06	1.1e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	1.35e-06	9.31e-06	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.04e-06	7.19e-06	CbGpPWpGaD
